Clinical Trial Update: Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 safety study assessing the combination of trastuzumab and cetuximab in patients with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Medical University of Vienna | Conditions: Metastatic Breast Cancer | Phase 1 | Status: UNKNOWN